Log in

NephCure and PNRC Pediatric Glomerular Disease Accelerator Grant Program


Scientific Review Committee

Scott Wenderfer, MD, PhD, FASN - Co-Chair


Scott Wenderfer, MD, PhD, FASN is Clinical Professor of Pediatrics at the University of British Columbia and Head, Division of Nephrology, at BC Children’s Hospital in Vancouver BC, Canada. He respectfully acknowledges that the land on which he lives, learns, teaches and practices is the unceded territory of the Coast Salish peoples, including the territories of the xʷməθkwəy̓əm (Musqueam), Skwxwú7mesh (Squamish), Stó:lō and Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh) Nations. Scott received his pediatrics and nephrology training at the University of Texas in Houston. His Waututh) Nations. Scott received his pediatrics and nephrology training at the University of Texas in Houston. His research interests include lupus nephritis, renal vasculitis, glomerulonephritis and nephrotic syndrome. He has been participating in the PNRC since 2012.

Jon B. Klein, MD, PhD - Co-Chair

Director, Clinical Translational Sciences Institute
Vice Dean for Research, School of Medicine
James Graham Brown Foundation Endowed Chair in Proteomics University of Louisville


Dr Klein, a New Orleans native, received much of his education in Texas attending the University of Texas at Austin for undergraduate education and received his medical degree from the University of Texas Medical Branch at Galveston, the original medical campus in the University of Texas System. He served a residency in Internal Medicine at Kansas University Medical Center and completed a fellowship in Adult Nephrology at the University of Louisville and subsequently earned a PhD in Microbiology and Immunology from the University of Louisville. He is Professor of Medicine and a clinical nephrologist practicing at the Robley Rex VA Medical Center. He currently holds the James Graham Brown Foundation Endowed Chair in Proteomics at the University of Louisville School of Medicine. His laboratory has received federal research grant funding from the National Institutes of Health, Veterans Administration, or Department of Energy continuously for more than 30 years. In 2013 he was appointed the Vice-Dean for Research at the University of Louisville School of Medicine. He has authored 230 peer-reviewed papers and is known in the kidney research community for introducing proteomic analysis to kidney research and subsequently as a co-discoverer of several target antigens in autoimmune kidney disease including the PLA 2 receptor in primary membranous nephropathy.

Antonia Bouts, MD, PhD, FGA - Committee Member

Assistant professor of Pediatric Nephrology, Emma Children’s Hospital, Amsterdam University Medical Center, the Netherlands


Dr. Bouts is a Pediatric Nephrologist in the Emma Children’s Hospital, Amsterdam University Medical Center

(AUMC), the Netherlands. She graduated from Maastricht University, the Netherlands. Dr. Bouts did her Pediatric Residency at Maastricht University Hospital and the Academic Medical Center, Amsterdam and her Pediatric Nephrology Fellowship at AUMC, location AMC, the Netherlands. She combined her fellowship with a PhD traject and defended her dissertation in 2001. Between 2000 and 2004 she worked in Leiden University Medical Center as general pediatrician and pediatric nephrologist. From 2004 until now she is working in the AUMC and responsible for the education of pediatric nephrology trainees. Dr. Bouts is coordinator of Pediatric Kidney Transplant Program and of expertise center for rare anomalies of kidneys and urinary tract in children of AUMC. She participates in the Dutch pediatric transplantation working group (KINT), the European Interdisciplinary Study Group of Pediatric Transplantation (Certain), the European Reference Network TransplantChild and ERKNet. For the ESPN she is chair of the Working Group Glomerular Diseases. She is Principle Investigator of the LEARNS Consortium granted by the

Dutch Kidney Foundation: a clinical and basic scientific study in children with first episode of idiopathic nephrotic syndrome focusing on the prevention of first relapse with combination therapy of prednisolone and levamisole, pharmacokinetics and pharmacodynamics of levamisole and prednisolone, Health-Related Quality of Life,\ Immunomics and Podocyte research.